Asprosin, but not subfatin, associated with non-obese polycystic ovary syndrome
Endokrynologia Polska · 2026
DOI: 10.5603/ep.108447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endokrynologia Polska, 2026. Verfasst von Reha Baran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye. rehabaran93@gmail.com. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Fibrillin-1, Adipokines, Microfilament Proteins.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye. rehabaran93@gmail.com.
- Department of Endocrinology, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye.
- Department of Biochemistry, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye.
ORCID-Profile: Reha Baran, Suzan Tabur, Seyithan Taysı, Esma Gülsun Arslan Cellat
Zitieren
APA
Baran, R., Tabur, S., Taysı, S., & Arslan Cellat, E. G. (2026). Asprosin, but not subfatin, associated with non-obese polycystic ovary syndrome. Endokrynologia Polska. https://doi.org/10.5603/ep.108447
Vancouver
Baran R, Tabur S, Taysı S, Arslan Cellat EG. Asprosin, but not subfatin, associated with non-obese polycystic ovary syndrome. Endokrynologia Polska. 2026. doi:10.5603/ep.108447
BibTeX
@article{Baran2026,
author = {Baran, Reha and Tabur, Suzan and Taysı, Seyithan and Arslan Cellat, Esma Gülsun},
title = {Asprosin, but not subfatin, associated with non-obese polycystic ovary syndrome},
journal = {Endokrynologia Polska},
year = {2026},
doi = {10.5603/ep.108447}
}
EUVIMED